Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research reveals how microbial context during infectious disease can compromise antibiotic therapy

Bacteria that are susceptible to antibiotics can survive when enough resistant cells around them are expressing an antibiotic-deactivating factor.

28 Dec 2016

New database of PCR primers enables effective detection and identification of RNA viruses

Scientists at Korea's Daegu Gyeongbuk Institute of Science and Technology scientists have compiled a comprehensive new public database of genetic information to enable the detection and identification of RNA viruses using the polymerase chain reaction assay.

28 Dec 2016

New comprehensive study lists top personal health expenses in the U.S.

Just 20 conditions make up more than half of all spending on health care in the United States, according to a new comprehensive financial analysis that examines spending by diseases and injuries.

28 Dec 2016

ACA financial penalties lead to reductions in hospital readmission rates for common conditions

Financial penalties levied under the Affordable Care Act's Hospital Readmissions Reduction Program lead to the poorest performing hospitals to achieve the greatest reductions in readmission rates for common conditions.

27 Dec 2016

MMJ Labs to launch new wearable pain therapy device at runDisney Health and Fitness Expo

MMJ Labs, LLC, industry leaders in non-invasive pain relief, will debut their newest product, VibraCool® Massaging Ice Therapy, at the runDisney Health and Fitness Expo in Orlando, FL.

26 Dec 2016

CSHL researcher-inventor hails FDA approval of new SMA drug

Within a week of Christmas day, a drug called nusinersen will be in the hands of doctors across the nation, who will use it, most urgently, to treat young children with a severe and potentially fatal illness called spinal muscular atrophy (SMA).

26 Dec 2016

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved SPINRAZATM (nusinersen) under Priority Review for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

26 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

MDA celebrates FDA approval of new spinal muscular atrophy drug

The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.

23 Dec 2016

Study examines mechanisms for measuring and reporting postoperative infection complications

How do medical professionals determine whether or not a patient has experienced a post-operative complication? A team of Mayo Clinic physicians and researchers has published results of a three-year study examining mechanisms for measuring and reporting postoperative infection complications.

23 Dec 2016

Cedars-Sinai expert explains how to recognize signs and symptoms of stroke during the holidays

Along with increased cheer and festivities during the holidays comes an increased risk of stroke, one of the leading causes of death and disability in the U.S.

23 Dec 2016

TSRI scientists shed light on how antiviral drug stops influenza infections

A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus.

22 Dec 2016

Researchers engineer promising live-attenuated RSV vaccine candidate

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

21 Dec 2016

TPC toxicologists warn about hidden dangers of button batteries to children

Button batteries are small round batteries found in items such as toys, greeting cards, watches, hearing aids, games and flashing jewelry—all products in the average American household during the holiday season.

20 Dec 2016

Texas A&M specialist explains what people need to know about mumps

Mumps may seem like a contagion relegated to history books, but like many other diseases of the past now preventable with a vaccine, mumps has been making a resurgence.

20 Dec 2016

Texas A&M professor shares tips to protect infants from RSV

Coughing, sneezing and a runny nose: You might think it is yet another cold, but if your baby is under 2 years old, it could very well be respiratory syncytial virus (RSV).

20 Dec 2016

ANTRUK's new research finds promising leads to combat antibiotic resistance

Antibiotic resistant infections are predicted to lead to 10 million deaths per year globally by 2050 at a cost of up to $100 trillion to the world economy. In the UK, at least 5,000 people per year die from resistant infections.

20 Dec 2016

How can we tackle antimicrobial resistance?

Antimicrobial resistance happens when bugs, like bacteria, fungi or viruses, change, or evolve, when they’re exposed to drugs, like antibiotics, antifungals, or antivirals. Bugs that develop antimicrobial resistance are sometimes referred to as ‘superbugs’.

20 Dec 2016

Researchers use DNA markers to differentiate harmless species from deadly bacteria

The virulent pathogen that causes the disease tularemia, or "rabbit fever," was weaponized during past world wars and is considered a potential bioweapon.

20 Dec 2016

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research reveals how microbial context during infectious disease can compromise antibiotic therapy

New database of PCR primers enables effective detection and identification of RNA viruses

New comprehensive study lists top personal health expenses in the U.S.

ACA financial penalties lead to reductions in hospital readmission rates for common conditions

MMJ Labs to launch new wearable pain therapy device at runDisney Health and Fitness Expo

CSHL researcher-inventor hails FDA approval of new SMA drug

New study shows efficacy of Ebola vaccine in offering protection against disease

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

MDA celebrates FDA approval of new spinal muscular atrophy drug

Study examines mechanisms for measuring and reporting postoperative infection complications

Cedars-Sinai expert explains how to recognize signs and symptoms of stroke during the holidays

TSRI scientists shed light on how antiviral drug stops influenza infections

Researchers engineer promising live-attenuated RSV vaccine candidate

TPC toxicologists warn about hidden dangers of button batteries to children

Texas A&M specialist explains what people need to know about mumps

Texas A&M professor shares tips to protect infants from RSV

ANTRUK's new research finds promising leads to combat antibiotic resistance

How can we tackle antimicrobial resistance?

Researchers use DNA markers to differentiate harmless species from deadly bacteria

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in